Moreover, intracerebroventricular administration of human Aβ42 improved the impaired hippocampal LTP in APP/PS1/Tau triple transgenic AD mice, an effect that was associated with the amelioration of cognitive deficits in the Y maze spontaneous alternation test and in the object-location task [168]. This evidence concerns the gene MAPT and Alzheimer disease.